Trial Profile
A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Aug 2016
Price :
$35
*
At a glance
- Drugs Hyaluronic acid/triamcinolone (Primary) ; Hyaluronic acid; Triamcinolone
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Carbylan Therapeutics
- 24 Aug 2016 Status changed from active, no longer recruiting to completed.
- 18 Feb 2016 New trial record